arbekacin has been researched along with Staphylococcal Pneumonia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, Y; Hashiguchi, K; Imamura, Y; Inoue, Y; Izumikawa, K; Kakeya, H; Kobayashi, T; Kohno, S; Kondo, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Yamamoto, Y; Yanagihara, K | 1 |
| Kawasumi, N; Kimura, M; Mikamo, H; Yamagishi, Y | 1 |
| Akiyama, N; Arai, T; Hanaki, H; Higashihara, M; Ichiwata, T; Ikegami, K; Kimura, T; Kobayashi, M; Matsumoto, T; Miyao, N; Nemoto, M; Oda, S; Ohyashiki, K; Otsuka, Y; Soma, K; Sunakawa, K; Suzuki, Y; Totsuka, K; Yokota, H; Yoshida, M; Yukioka, T | 1 |
| Arakawa, M; Honma, T; Hoshino, S; Miyao, H; Sato, S; Sega, H; Shimazu, Y; Tsukada, H; Wada, K; Yoshikawa, H | 1 |
| Kanno, S; Kawashima, T; Kikuchi, N; Kunitomo, F; Kuriyama, T; Mizutani, F; Nakamura, H; Shishibara, T; Watanabe, M; Yamagishi, F | 1 |
| Imai, T; Ito, A; Matsumoto, F; Odagiri, S; Sakurai, I; Sugiyama, M; Sumitomo, M; Suzuki, M; Takahashi, K; Yoshikawa, K | 1 |
| Abe, T; Fujii, R; Fujita, K; Meguro, H; Mikuni, K; Sakai, T; Sakata, Y; Tajima, T; Terashima, I; Watanabe, N | 1 |
4 trial(s) available for arbekacin and Staphylococcal Pneumonia
| Article | Year |
|---|---|
The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Dibekacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Sepsis; Staphylococcal Infections; Treatment Outcome | 2012 |
[Clinical efficacy of arbekacin on MRSA pneumonia].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Kidney; Liver; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcus aureus | 1994 |
[An evaluation study on arbekacin for MRSA-infectious diseases including pneumonia, septicemia and others].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Dibekacin; Drug Therapy, Combination; Female; Humans; Kidney; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Clinical studies of arbekacin sulfate in the pediatric field].
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Dibekacin; Female; Humans; Infant; Infant, Newborn; Male; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 1994 |
3 other study(ies) available for arbekacin and Staphylococcal Pneumonia
| Article | Year |
|---|---|
[Clinical investigation of arbekacin sulfate based on Cmax/MIC].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Dibekacin; Gram-Positive Cocci; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal | 2012 |
Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Dibekacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Japan; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Sepsis | 2013 |
[Clinical analysis of MRSA pneumonia. Niigata Research Group of MRSA.ABK].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Female; Humans; Japan; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 1994 |